Author： Kümmerer Klaus
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.29, Iss.5, 2006-01, pp. : 371-373
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Communicating the New Pharmacovigilance Landscape
Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. :
Access to resources
Recommend
Pharmacovigilance for New Drugs
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 41, Iss. 4, 2011-12 ,pp. :
Clinical Diagnosis: A Topic Worth Revisiting for Pharmacovigilance
Drug Safety, Vol. 35, Iss. 4, 2012-04 ,pp. :
Digging for a new gold standard in pharmacovigilance
Reactions Weekly, Vol. 1, Iss. 1167, 2007-01 ,pp. :
Understanding new EU pharmacovigilance rules
Reactions Weekly, Vol. 1, Iss. 1344, 2011-01 ,pp. :